Pharmagest Interactive SA
F:PHF

Watchlist Manager
Pharmagest Interactive SA Logo
Pharmagest Interactive SA
F:PHF
Watchlist
Price: 34.5 EUR -34.62% Market Closed
Market Cap: €518.6m

Balance Sheet

Balance Sheet Decomposition
Pharmagest Interactive SA

Balance Sheet
Pharmagest Interactive SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
2
3
8
5
8
2
2
2
8
5
9
11
16
13
10
14
21
26
21
34
35
23
18
0
Cash
0
0
0
0
0
0
0
2
3
4
6
6
6
5
4
6
11
18
10
27
23
23
18
0
Cash Equivalents
2
3
8
5
8
2
2
0
5
1
3
5
10
7
6
9
10
7
12
7
12
0
0
0
Short-Term Investments
9
15
14
13
14
14
15
15
16
22
23
31
29
35
41
28
28
29
29
30
30
45
36
31
Total Receivables
7
6
12
10
10
14
13
19
13
14
14
15
18
19
20
26
32
40
43
41
49
60
67
65
Accounts Receivables
6
5
10
9
8
12
12
18
10
12
12
13
15
15
16
20
23
32
35
32
37
47
53
47
Other Receivables
0
1
2
2
2
2
1
2
2
2
2
2
3
3
4
6
9
8
8
9
11
13
14
17
Inventory
1
2
2
3
3
2
2
1
2
2
2
2
2
2
2
3
3
5
4
7
9
9
10
10
Other Current Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
13
7
7
0
0
0
0
0
0
Total Current Assets
19
25
36
30
34
32
30
38
39
43
48
59
65
69
78
84
90
107
98
111
122
137
132
122
PP&E Net
1
1
2
4
4
4
4
4
4
4
4
4
4
4
5
6
6
9
20
28
28
27
33
30
PP&E Gross
1
1
2
4
4
4
4
4
4
4
4
4
4
4
5
6
6
9
20
28
28
27
33
30
Accumulated Depreciation
1
2
2
3
3
4
4
4
5
5
6
6
7
7
8
9
10
13
16
21
27
32
34
35
Intangible Assets
6
6
6
1
2
6
8
9
10
10
10
9
11
11
12
14
19
24
30
37
40
39
40
46
Goodwill
1
1
4
15
15
24
26
27
27
27
27
27
28
28
28
31
39
46
50
66
84
83
90
104
Long-Term Investments
0
0
0
0
0
0
0
0
0
1
3
2
1
1
1
16
20
36
59
53
55
63
95
92
Other Long-Term Assets
1
0
0
0
1
1
1
1
1
1
0
0
0
1
0
0
4
3
3
2
2
3
4
3
Other Assets
1
1
4
15
15
24
26
27
27
27
27
27
28
28
28
31
39
46
50
66
84
83
90
104
Total Assets
28
N/A
33
+19%
48
+45%
51
+7%
56
+9%
67
+20%
70
+5%
79
+12%
80
+2%
85
+6%
91
+7%
102
+12%
109
+7%
114
+4%
124
+9%
151
+22%
178
+18%
224
+26%
258
+15%
296
+15%
330
+12%
351
+6%
394
+12%
398
+1%
Liabilities
Accounts Payable
4
3
7
7
7
7
6
5
7
7
7
8
8
6
7
8
10
12
13
14
16
17
16
14
Short-Term Debt
0
0
0
0
0
1
4
4
0
0
0
0
1
0
0
6
0
1
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
1
1
3
3
3
3
3
2
2
1
0
0
1
3
5
10
17
17
18
22
19
Other Current Liabilities
3
7
8
12
14
13
11
15
16
17
19
21
21
22
20
24
40
47
49
50
61
63
70
69
Total Current Liabilities
7
10
15
20
22
23
24
28
27
27
27
31
30
28
27
39
52
65
72
81
94
98
108
102
Long-Term Debt
0
0
7
6
5
12
11
10
7
5
3
1
1
1
1
3
14
37
37
55
57
46
45
28
Deferred Income Tax
0
0
0
0
0
1
1
1
1
1
1
0
0
0
1
1
1
1
1
1
1
2
2
2
Minority Interest
0
0
3
3
3
0
1
1
1
1
1
0
0
0
1
2
2
3
4
6
6
7
8
9
Other Liabilities
2
1
2
0
1
1
1
1
1
2
2
2
2
2
4
4
6
5
17
10
12
8
12
26
Total Liabilities
9
N/A
12
+30%
26
+118%
29
+9%
30
+6%
38
+24%
37
-2%
41
+10%
37
-10%
35
-5%
33
-4%
35
+7%
34
-5%
32
-5%
33
+3%
49
+46%
76
+55%
110
+45%
131
+19%
153
+17%
171
+12%
161
-6%
175
+9%
167
-5%
Equity
Common Stock
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
Retained Earnings
2
5
5
19
22
26
30
35
41
47
55
63
73
78
88
99
99
111
125
140
156
187
216
238
Additional Paid In Capital
13
13
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
18
N/A
21
+14%
22
+3%
22
+4%
25
+13%
29
+16%
33
+14%
38
+14%
44
+15%
50
+15%
58
+15%
67
+15%
76
+14%
81
+8%
91
+12%
102
+12%
103
+0%
114
+11%
128
+12%
143
+12%
159
+11%
190
+19%
219
+16%
232
+6%
Total Liabilities & Equity
28
N/A
33
+19%
48
+45%
51
+7%
56
+9%
67
+20%
70
+5%
79
+12%
80
+2%
85
+6%
91
+7%
102
+12%
109
+7%
114
+4%
124
+9%
151
+22%
178
+18%
224
+26%
258
+15%
296
+15%
330
+12%
351
+6%
394
+12%
398
+1%
Shares Outstanding
Common Shares Outstanding
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett